These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

937 related articles for article (PubMed ID: 6139800)

  • 41. On the antihypertensive mechanisms of beta-adrenoceptor antagonists in relation to intrinsic sympathomimetic activity, cardioselectivity and hydrophilicity.
    Man in't Veld AJ; Schalekamp MA
    J Pharmacol; 1983; 14 Suppl 2():69-104. PubMed ID: 6138473
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Haemodynamic effects of selective alpha 1-blockade (trimazosin) in essential hypertension.
    Nelson GI; Hussain M; Forsyth D; Wilson J; Silke B; Taylor SH
    J Cardiovasc Pharmacol; 1984; 6(1):176-81. PubMed ID: 6199601
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Systemic, pulmonary and coronary haemodynamic actions of the novel dopamine receptor agonist in awake pigs at rest and during treadmill exercise Z1046.
    Duncker DJ; Haitsma DB; van der Geest IE; Stubenitsky R; van Meegen JR; Man in't Veld AJ; Verdouw PD
    Br J Pharmacol; 1997 Mar; 120(6):1101-13. PubMed ID: 9134223
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effect of some beta-blocking drugs on plasma renin activity, platelet adhesiveness and dilute blood clot lysis time in patients with essential arterial hypertension.
    Vlaicu R; Uza G; Mărcuş C; Voinescu I
    Med Interne; 1980; 18(3):247-51. PubMed ID: 6106281
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Effect of beta blockers with intrinsic sympathomimetic activity on blood pressure and blood lipids in patients with essential hypertension].
    Serro-Azul JB; Wajngarten M; Santomauro A; Braga A; Yazbek Júnior P; Bellotti G; Serro-Azul LG; Pileggi F
    Arq Bras Cardiol; 1989 Dec; 53(6):321-5. PubMed ID: 2700113
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The response of plasma catecholamines to the vasodepression caused by beta-adrenoceptor antagonists in the spontaneously hypertensive rat.
    Keeton TK
    J Hypertens Suppl; 1986 Oct; 4(3):S197-9. PubMed ID: 2878069
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Hemodynamic changes under metoprolol compared to propranolol in hypertensive patients].
    Pfisterer M; Burkart F; Bühler FR; Schweizer W
    Schweiz Med Wochenschr; 1976 Nov; 106(45):1567-9. PubMed ID: 1013675
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intravenous beta-blockade in coronary heart disease: is cardioselectivity or intrinsic sympathomimetic activity hemodynamically useful?
    Taylor SH; Silke B; Lee PS
    N Engl J Med; 1982 Mar; 306(11):631-5. PubMed ID: 6120457
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antihypertensive actions of an isomer of labetalol and other vasodilator-beta-adrenoceptor blockers.
    Baum T; Sybertz EJ
    Fed Proc; 1983 Feb; 42(2):176-81. PubMed ID: 6130003
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Beta-blockers in the treatment of hypertension: are there clinically relevant differences?
    Weir MR
    Postgrad Med; 2009 May; 121(3):90-8. PubMed ID: 19491545
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Haemodynamic response to antihypertensive treatment with atenolol in patients with hypertension (author's transl].
    Zilcher H; Glogar D; Uhlir H; Leisch F; Niederberger M; Steinbach K
    Wien Klin Wochenschr; 1978 Sep; 90(16):611-6. PubMed ID: 695651
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Therapy of hypertension. I. new antihypertensive agents, pharmacologic and pharmacokinetic bases. Beta-adrenergic blockers and blood pressure lowering].
    Brunner H
    Verh Dtsch Ges Kreislaufforsch; 1977; 43():75-86. PubMed ID: 26152
    [No Abstract]   [Full Text] [Related]  

  • 53. The effect of prindolol on plasma noradrenaline, plasma renin and sodium-potassium metabolism in patients with essential hypertension.
    Brecht HM; Werner E; Schoeppe W
    Adv Clin Pharmacol; 1976; 11():66-9. PubMed ID: 1032572
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ketanserin: a possible tool for studying the role of serotonin in hypertension.
    Woittiez AJ; Wenting GJ; Man in't Veld AJ; Boomsma F; Schalekamp MA
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S130-6. PubMed ID: 2412035
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Renin and age as determinants of a predominantly betablocker-based antihypertensive drug program.
    Bühler FR; Lütold BE
    Adv Nephrol Necker Hosp; 1976; 6():303-17. PubMed ID: 14485
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hemodynamic and endocrine changes associated with hypotensive action of amosulalol in essential hypertension.
    Ando K; Noda H; Ogata E; Fujita T
    J Cardiovasc Pharmacol; 1992 Jul; 20(1):7-10. PubMed ID: 1383633
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Different pharmacological properties of two enantiomers in a unique beta-blocker, nebivolol.
    Ignarro LJ
    Cardiovasc Ther; 2008; 26(2):115-34. PubMed ID: 18485134
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Renin and beta-blockade: prorenin and aldosterone may explain the controversy.
    McKenna F; Davison AM
    Clin Nephrol; 1986 Mar; 25(3):149-54. PubMed ID: 2869848
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Long-term minoxidil therapy: renin, aldosterone, noradrenaline and the need for beta blockers].
    Jaeger P; Brunner HR; Turini GA; Jéquier E; Ferguson RK; Gavras H
    Schweiz Med Wochenschr; 1978 Nov; 108(44):1707-9. PubMed ID: 715407
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Hemodynamic effects and effects on plasma renin activity of injectable acebutolol in arterial hypertension].
    Lekieffre J; Carré A; Ginestet A; Dewailly P; Warembourg H
    Nouv Presse Med; 1975 Dec; 4(46 Suppl):3247-51. PubMed ID: 768906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 47.